Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEUPROLIDE Cause Intentional product use issue? 1,644 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 1,644 reports of Intentional product use issue have been filed in association with LEUPROLIDE (Fensolvi). This represents 2.3% of all adverse event reports for LEUPROLIDE.

1,644
Reports of Intentional product use issue with LEUPROLIDE
2.3%
of all LEUPROLIDE reports
47
Deaths
189
Hospitalizations

How Dangerous Is Intentional product use issue From LEUPROLIDE?

Of the 1,644 reports, 47 (2.9%) resulted in death, 189 (11.5%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 1,644 reports have been filed with the FAERS database.

What Other Side Effects Does LEUPROLIDE Cause?

Hot flush (9,146) Death (8,772) Intercepted product preparation error (8,621) Syringe issue (7,847) Device leakage (5,861) Wrong technique in product usage process (5,062) Fatigue (4,805) Injection site pain (4,678) Prostatic specific antigen increased (2,432) Asthenia (2,176)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which LEUPROLIDE Alternatives Have Lower Intentional product use issue Risk?

LEUPROLIDE vs LEVALBUTEROL LEUPROLIDE vs LEVAMISOLE LEUPROLIDE vs LEVAQUIN LEUPROLIDE vs LEVEMIR LEUPROLIDE vs LEVETIRACETAM

Related Pages

LEUPROLIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue LEUPROLIDE Demographics